The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8‐week, prospective, open‐label, multicenter, single‐arm study

INTRODUCTION: This study evaluated the effectiveness and safety of amisulpride in Chinese schizophrenia patients. METHODS: A multicenter, single‐arm Phase IV study (NCT01795183). Chinese patients with schizophrenia received amisulpride for 8 weeks. The primary endpoint was ≥50% decrease in Positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Ying, Cao, Changan, Zhu, Cheng, Wang, Chuanyue, Zhang, Congpei, Dong, Fang, Yang, Fude, Deng, Hong, Yu, Jingjie, Tang, Jisheng, Su, Lei, Xin, Limin, Hong, Ling, Gao, Minglong, Tang, Muni, Xie, Shiping, Lu, Shuiping, Liu, Tiebang, Xu, Xiaojin, Wang, Xijin, Li, Xuanzi, Wang, Xueyi, Li, Yi, Zhang, Yong, Chen, Zhiyu, Yu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071681/
https://www.ncbi.nlm.nih.gov/pubmed/27020720
http://dx.doi.org/10.1111/appy.12238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071681/
https://www.ncbi.nlm.nih.gov/pubmed/27020720
http://dx.doi.org/10.1111/appy.12238

Ejemplares similares